Table 1.
The relationship between DDX11 expression and the clinicopathological features of lung adenocarcinoma patients
| Clinicopathological features | No. of cases (%) | DDX11 expression level | P value | ||
|---|---|---|---|---|---|
| Low | High | ||||
| Age (years) | ≤40 | 41 | 15 | 26 | 0.458 |
| >40 | 45 | 20 | 25 | ||
| Gender | Female | 40 | 18 | 22 | 0.448 |
| Male | 46 | 17 | 29 | ||
| TNM | Ⅰ and Ⅱ | 40 | 22 | 18 | 0.013* |
| Ⅲ and Ⅳ | 31 | 8 | 23 | ||
| NA | 15 | 5 | 10 | ||
| Histological type | Mixed Subtype | 57 | 24 | 23 | 0.264 |
| Other Subtype | 29 | 11 | 18 | ||
| Tumour size | ≤3 cm | 32 | 18 | 14 | 0.023* |
| >3 cm | 54 | 17 | 37 | ||
Notes: *P<0.05. **P<0.01.
Abbreviations: TNM: tumour-node-metastasis; NA: not available; HR: hazard ratio; CI: confidential interval; DDX11: DEAD/H-box helicase 11.